Studies of post-exposure prophylaxis with doxycycline should consider population-level selection for antimicrobial resistance

Lancet Infect Dis. 2024 Oct;24(10):e606-e607. doi: 10.1016/S1473-3099(24)00502-4. Epub 2024 Aug 21.

Authors

Thibaut Vanbaelen¹, Sheeba Santhini Manoharan-Basil¹, Chris Kenyon²

Affiliations

¹ STI Unit, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp 2000, Belgium.
² STI Unit, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp 2000, Belgium; Division of Infectious Diseases and HIV Medicine, University of Cape Town, Cape Town, South Africa. Electronic address: [email protected].

PMID: 39181147
DOI: 10.1016/S1473-3099(24)00502-4

No abstract available

Publication types

Letter

MeSH terms

Anti-Bacterial Agents* / administration & dosage
Anti-Bacterial Agents* / therapeutic use
Doxycycline* / administration & dosage
Doxycycline* / therapeutic use
Drug Resistance, Bacterial*
Humans
Post-Exposure Prophylaxis*

Substances

Doxycycline
Anti-Bacterial Agents